Stock screener

BCRX

Conviction 71HealthcareScan · Thu, Jun 25, 2026
Bearish harami
BCRX$9.90-1.00%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 5.59M
Mar 26Apr 14May 1May 19Jun 8Jun 25
BIOCRYST PHARMACEUTICALS INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.biocryst.com
Price9.90
Change-1.00%
Gap-0.20%
Rel volume3.49×
Avg volume5.01M
Avg $ vol45.25M
SMA 208.82
SMA 508.91
SMA 2007.96
Price vs 50+11.14%
Price vs 200+24.34%
MA stackbullish
50/200 cross
Supertrendup · 8.81
RSI (14)68
MACD hist0.16
MACD crossbull · 8d
Stoch %K / %D63 / 82
ADX (14)22
+DI / −DI41 / 12
RSI divergence
MACD divergenceBullish
ATR %+4.78%
ADR %4.40%
52w high10.00
52w low6.24
From 52w high-1.00%
Above 52w low+58.65%
New 52w highNo
SqueezeOff
Bollinger width22.47%
%B1.04
Donchian pos63.89%
Donchian high10.94
Donchian low8.06
AVWAP (52w high)10.18
vs AVWAP high-2.73%
AVWAP (52w low)8.06
vs AVWAP low+22.76%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d3.49×
Avg vol (14d)5.59M
Avg vol (20d)5.01M
Avg $ vol (20d)45.25M
Market cap2.52B
RS 3m (vs SPY)-8.74%
RS 6m (vs SPY)+27.22%
RS line new highNo
Trend template7/8
Technical rank87.6
1 week+10.61%
1 month+16.88%
3 months+5.32%
6 months+30.09%
1 year-0.30%
YTD+32.00%
P/E9.54
P/B-4.54
P/S99.91
P/FCF7.25
EPS1.21
Div yield
ROE-47.64%
ROA56.74%
Debt/Eq-0.71
Current1.91
EV/EBITDA8.00
Gross margin
Net margin
Rev growth-4.43%
EPS growth396.87%
Price target23.33
Target upside135.66%
Analyst ratingBuy
Institutional108.45%
Ent. value2.74B
Revenue8.76M
Net income-721.81M
Gross profit
Free cash flow347.03M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out254.16M
Employees435
ListedThu, Mar 3, 1994
Free float199.32M
Float %94.6%
Short interest36.65M
Days to cover9.4d
Short volume62.8%
Squeeze score92 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast$0.14 · 3 est
Last EPS vs est−$0.03 vs $0.06
Last surprise-150.0% miss
Setup gradeB
Conviction71 / 100
Pattern quality
Tech rank87.6 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish harami
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BCRX · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-13
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in BCRX · 6 buys · 3 sells

InsiderSideShares
Frank Steven
Director · Common Stock · 2026-05-29
Grant1.26K
Stonehouse Jon P
Director · Common Stock · 2026-05-29
Grant631
Stonehouse Jon P
Director · Common Stock · 2026-05-29
Other
MILANO VINCENT
Director · Common Stock · 2026-05-29
Grant1.12K
McKee Amy E
Director · Common Stock · 2026-05-29
Grant631
Milne Jill C.
Director · Common Stock · 2026-05-29
Grant1.26K
McKee Amy E
Director · Common Stock · 2026-05-18
Sell11.18K
Barnes Alane P
Chief Legal Officer · Emp. Stock Option (Right to Buy) · 2026-05-13
Exercise62.5K
Barnes Alane P
Chief Legal Officer · Common Stock · 2026-05-13
Sell62.5K
Barnes Alane P
Chief Legal Officer · Common Stock · 2026-05-13
Exercise62.5K

SEC filings

EDGAR filings in BCRX · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.